Member Info for Wheaten76

I added more, I coudn’t help myself!

Yes I was looking at this trial the other day. Good spot that it’s finished recruiting.

I agree , huge potential here. The use of the American medical acronym MDD in the RNS was copied from the Vistagen site. I have a UK medical background and had to Google to find out it stands for Major Depressive Disorder. Then I thought, “Wow...”

It’s a shame that this RNS was overshadowed by the business update, which essentially told us what we already knew.

The potential from the Vistagen collaboration is huge. Neither the market or this bulletin board seems to have grasped the significance of the application of co-crystal technology in a drug being developed as an adjunct in major depressive disorder and neuropathic pain. Branching out into developing treatments for central nervous system disorders is a really exciting development for NFX.

I’m topping up every month and can’t see any reason to stop. This is a long term investment. Sure I check for an RNS every morning and news would be good but the science is sound here. GLA.

I’ve taken the opportunity to top again this morning. The science here is sound. We just need to be patient. News will come when it comes.